Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-900-3 | CAS number: 7778-18-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
In a OECD guideline combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (NIER 2002), calcium sulfate, dihydrate was administered by gavage at the dose levels of 0, 100, 300 and 1,000 mg/kg bw/day for more than 35 days and 41~45 days for male and female rats respectively and the pre-mating exposure period was 14 days. No adverse effects were observed in terms of fertility, delivery and nursing in parent animals during the test period. There were no signs of reproduction/developmental toxicity on the body weight gestation index, sex ratio, clinical signs or viability up to 1,000 mg/kg/day (highest dose tested). According to the result of reproductive toxicity screening test, the NOAEL for calcium sulfate dihydrate was the highest dose tested (1000 mg/kg day) which equates to 790 mg/kg bw day for calcium sulfate anhydrous.
Calcium sulfate dihydrate showed no signs of reproduction/developmental toxicity in an OECD 422 reproduction/developmental screening test.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to GLP and guideline
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8 weeks
- Weight at study initiation: 254.2 - 297.8 g (males) and 182.7 - 208.2 g (females) - Route of administration:
- oral: gavage
- Details on mating procedure:
- - M/F ratio per cage: 1:1 (from same test group)
- Length of cohabitation: 4 days
- Proof of pregnancy:sperm in vaginal smear - Duration of treatment / exposure:
- Premating exposure period of 2 weeks
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 60
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- A pre-treatment test was conducted with 0, 125, 250, 500 and 1,000 mg/kg/day of test substance for 7 days to determine the appropriate starting dose level.
- Parental animals: Observations and examinations:
- Clinical observations performed and frequency: Clinical symptoms were observed once a day but were observed once a week in detail; a death rate was observed twice a day; and body weight was observed once a week and just before the necropsy, but in case of pregnant females, it was measured on the day 0, 7, 14, 20 of gestation period, date of delivery, and 4 days after the delivery; consumption rate of fodder was observed once a week except mating period.
- Litter observations:
- Observation of F1:
The number of survivors and deaths during delivery
Body weight and Survival rate: measured on the day 0 and 4 after the delivery - Postmortem examinations (parental animals):
- A number of implantation and corpus luteum: while female animals were necropsied, the number of corpus leteum and implantation were
counted; and the former was measured in the ovary and the latter was measured in the uterus.
Organ weight: testes, epididymider (all males) liver, kidney, adrenals, thymus, spleen, brain, and heart (5 male and female animals from each test group).
- Fixation: 22 kinds of tissues were fixed to do histopathologic tests such as testes, epididymides, ovaries, accessory sex organs for all animals, brain (including cerebrum, cerebellum and pons), spinal cord, stomach, small and large intestines (including peyer’s patches), liver, kidneys, adrenals, spleen, heart, thymus, thyroid, trachea, lungs, uterus, urinary bladder, lymph nodes (cervical mesenteric), peripheral nerve (sciatic or tibial), bone marrow. - Statistics:
- Statistical decision tree, but in case of recovery group, either two-side Students t-test or two-side Apsin Welch t-test was used. In case of categorical data, two-sided Fishers exact test was used.
- Dose descriptor:
- NOAEL
- Remarks:
- reproductive toxicity
- Effect level:
- 790 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The result has been corrected to calcium sulfate anhydrous
- Critical effects observed:
- no
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 790 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: The result has been corrected for calcium sulfate anhydrous
- Critical effects observed:
- no
- Reproductive effects observed:
- no
- Conclusions:
- According to the results of the reproductive toxicity test the NOAEL was the highest dose tests (1000 mg/kg) which was corrected to 790 mg/kg for calcium sulfate anhydrous. Calcium sulfate was not considered to be toxic to reproduction or development
Reference
Index of copulation, fertility and gestation: Every test group including control group was succeeded in the mating, but each animal from every group was not succeeded in the gestation. However, all pregnant female animals were succeeded in the delivery. Therefore, no significant difference between the treatment group and the control group was found.
- Clinical signs: In male control group, a case of salivation and bloodylike secretion was observed on the day 11 and 12. In the 1,000 mg/kg/day treatment group, a case of depilation, dcab and pus was observed on the left cheek between the day 25 and the closing day. However, the frequency of occurrence was low and no dose-response correlation. Thus these symptoms were not influenced by test substance. In female control group, a case of genitalia bloody-like secretion was observed at day 29. In the 100 mg/kg/day treatment group, each case of hypoactivity and depilation was observed on the day 8 and 9, and between day 44 and the closing day, respectively. However, these symptoms were disappeared in short, thus these symptoms did not have relationship with test substance.
Necropsy opinions: For male animals, in the control group within the recovery group, a case of left and right caput epididymis cyst was observed and the 1,000 mg/kg/day recovery group had symptom of right caput epididymis cyst. However, its frequency of occurrence was low and it was even observed at the control group within the recovery group, so it did not have relationship with test substance. For female animals, in the 300 mg/kg/day treatment group, each animal was dead on the day 7 and 14 and; each case of lung dark-red discolouration was observed, but white particles in a lobe of the lung was observed just from one of carcasses. A case of spleen white nodule was observed for an animal in the 300 mg/kg/day treatment group. There was a case of right adrenal gland white spots at the 1,000 mg/kg/day treatment group. In the control group within the recovery group, each case of right adrenal gland hemorrhagia and atrophy and liver adhesion with diaphragm was observed. However, their frequencies of occurrence were low and no dose-response correlation, so these did not have relationship with test substance.
Table 1:
DOSE: (mg/kg) |
0 |
100 |
300 |
1000 |
No. of mated males Copulation index (%) Fertility index (%) No. of mated females Copulation index (%) Fertility index (%) Gestation index (%) No. of corpora lutea Mean ± S.D No. of implantations Mean ± S.D Mean % preimplantation loss No. of embryo/fetal death No. of live pups born Mean ± S.D Mean pregnancy period (day) Viability index on day at birth(%) Viability index on day 4 pp (%) Body weights of pups (g) Male (at birth) 4 DAY Female (at birth) 4 DAY |
12 100.0 91.7 12 100.0 91.7 100.0 17.2 2.6 15.1 2.5 11.6 1.5 13.5 2.2 21.8 99.0 98.0
6.49 9.78 6.19 9.44 |
12 100.0 91.7 12 100.0 91.7 100.0 17.0 3.4 13.6 4.1 20.2 1.0 12.6 4.0 21.7 99.4 98.3
6.42 9.86 6.06 9.13 |
10 100.0 90.0 10 100.0 90.0 100.0 17.4 3.5 15.7 1.9 9.0 0.7 15.0 1.8 22.0 98.0 97.8
6.56 9.70 6.23 9.37 |
12 100.0 91.7 12 100.0 91.7 100.0 17.2 1.9 15.4 4.3 10.3 0.7 14.6 4.5 22.0 100.0 97.6
6.55 9.52 6.26 8.74 |
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 790 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
In a guideline equivalent teratology study (Morgareidge 1974) mice, rats and rabbits were dosed by oral gavage with calcium sulfate up to 1600 mg/kg. Body weights of live pups were recorded and all foetuses were examined for the presence of external congenital abnormalities. One third of the foetuses for each litter underwent detailed visceral examinations.
Administration of up to 1600 mg/kg bw of calcium sulfate to pregnant mice for 10 consecutive days had no clearly discernable effects on nidation or on maternal or foetal survival.
Administration of up to 1600 mg/kg bw of calcium sulfate to pregnant rats for 10 consecutive days had no clearly discernable effects on nidation or on maternal or foetal survival.
Rabbits: up to 1600 mg/kg bw of calcium sulfate to pregnant rabbits for 13 consecutive days had no clearly discernable effects on nidation or on maternal or foetal survival.
Calcium sulfate had no effects on nidation or on maternal or foetal survival in mice,rats and rabbits at doses up to 1600 mg/kg bw.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study is well documented and comparabale to a guideline but not performed to GLP
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- no
- Remarks:
- Predates GLP
- Limit test:
- no
- Species:
- other: mice, rats and rabbits
- Strain:
- other: Albino CD-1 outbred mice; Wistar derived albino rats; Dutch-belted rabbits
- Details on test animals or test system and environmental conditions:
- Mice:
Adult virgin mice were gang-housed in disposable plastic cages in temperature and humidty controlled quarters with free access to food and fresh tap water.
Rats:
Adult virgin rats were individually housed in mesh bottom cages in temperature and humidity-controlled quarters with free access to food and fresh tap water.
Rabbits:
Adult virgin rabbits were individually housed in mesh bottom cages in temperature and humidity-controlled quarters with free access to food and fresh tap water. - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on exposure:
- Mice: beginning on Day 6 and continuing daily through Day 15 of gestation the females were dosed with the indicated doses.
Rats: beginning on Day 6 and continuing daily through Day 15 of gestation the females were dosed with the indicated doses.
Rabbits: beginning on Day 6 and continuing daily through Day 18 the females were dosed. - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- None specified
- Details on mating procedure:
- Mice: mated with young adult males, and observation of the vaginal sperm plug was considered Day 0 of gestation.
Rats: mated with young adult males, and observation of the vaginal sperm plug was considered Day 0 of gestation.
Rabbits: On Day 0, each doe was given an injection of 0.4 mL of human chorionic gonadotrophin (400 IU) via the marginal ear vein. Three hours later, each doe was inseminated artificially with 0.3 mL of diluted semen from a proven donor buck using approximately 20E+06 motile sperm according to the procedure described by Vogin et al. - Duration of treatment / exposure:
- Mice: 10 days
Rats: 10 days
Rabbits: 13 days - Frequency of treatment:
- Daily
- Duration of test:
- Mice: 17 days
Rats: 20 days
Rabbits: 29 days - Dose / conc.:
- 16 mg/kg bw/day
- Remarks:
- Species: mice, rats, rabbits
- Dose / conc.:
- 74.3 mg/kg bw/day
- Remarks:
- Species: mice, rats, rabbits
- Dose / conc.:
- 345 mg/kg bw/day
- Remarks:
- Species: mice, rats, rabbits
- Dose / conc.:
- 1 600 mg/kg bw/day
- Remarks:
- Species: mice, rats, rabbits
- No. of animals per sex per dose:
- Mice: Mated animals 24-30
Rats: Mated animals 25
Rabbits: Mated animals 20-22
Refer to tables 3 (mice) table 4 (rats) and table 5 (rabbits) - Control animals:
- yes, sham-exposed
- other: Asprin was used as the positive control in mice at a dose of 150 mg/kg and in rats at a dose of 250 mg/kg ... (see attached file)
- Details on study design:
- None specified
- Maternal examinations:
- Mice:
Body weights were recorded on Days 0, 6, 11, 15 and 17 of gestation.
All animals were observed daily for appearance and behaviour with particular attention to food consumption and weight in order to rule out any abnormalities which may have occurred as a result of anorexic effects in the pregnant female animal. The urogenital tract of each dam was examined in detail for anatomical abnormality.
Rats:
Body weights were recorded on Days 0, 6, 11, 15 and 20 of gestation.
All animals were observed daily for appearance and behaviour with particular attention to food consumption and weight in order to rule out any abnormalities which may have occurred as a result of anorexic effects in the pregnant female animal. The urogenital tract of each dam was examined in detail for anatomical abnormality.
Rabbits:
Body weights were recorded on Days 0, 6, 12, 18 and 29 of gestation.
All animals were observed daily for appearance and behaviour with particular attention to food consumption and weight in order to rule out any abnormalities which may have occurred as a result of anorexic effects in the pregnant female animal. The urogenital tract of each dam was examined in detail for anatomical abnormality. - Ovaries and uterine content:
- Mice:
Number of implanation sites, resorption sites and live and dead foetuses were recorded.
Rats:
Number of implanation sites, resorption sites and live and dead foetuses were recorded.
Rabbits:
The number of corpora lutea, implanation sites, resorption sites and live and dead foetuses were recorded. - Fetal examinations:
- Mice:
Body weights of live pups were recorded. All foetuses were examined for the presence of external congenital abnormalities. One third of the foetuses for each litter underwent detailed visceral examinations employing the Wilson technique. The remaining two-thirds were cleared in potassium hydroxide (KOH), stained with alizarin red S dye and examined for skeletal defects.
Rats:
Body weights of live pups were recorded. All foetuses were examined for the presence of external congenital abnormalities. One third of the foetuses for each litter underwent detailed visceral examinations employing the Wilson technique. The remaining two-thirds were cleared in potassium hydroxide (KOH), stained with alizarin red S dye and examined for skeletal defects.
Rabbits:
Body weights of live pups were recorded. All foetuses were examined for the presence of external congenital abnormalities. The live foetuses of each litter were then placed in an incubator for 24 h for the evaluation of neonatal survival. All surviving pups were sacrificed and all pups were examined for visceral abnormalities by dissection. All foetuses were then cleared in potassium hydroxide (KOH), stained with alizarin red S dye and examined for skeletal defects. - Statistics:
- None specified
- Indices:
- None specified
- Historical control data:
- None specified
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
Not applicable - Dose descriptor:
- NOAEL
- Remarks:
- Mice
- Effect level:
- 1 600 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: no clearly discernable effects on nidation or on maternal or foetal survival.
- Dose descriptor:
- NOAEL
- Remarks:
- Rats
- Effect level:
- 1 600 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: no clearly discernable effects on nidation or on maternal or foetal survival.
- Dose descriptor:
- NOAEL
- Remarks:
- Rabbits
- Effect level:
- 1 600 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: no clearly discernable effects on nidation or on maternal or foetal survival.
- Abnormalities:
- no effects observed
- Reduction in number of live offspring:
- no effects observed
- Skeletal malformations:
- no effects observed
- Visceral malformations:
- no effects observed
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
Not applicable - Dose descriptor:
- NOAEL
- Effect level:
- 1 600 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: no clearly discernable effects on nidation or on maternal or foetal survival. The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls.
- Abnormalities:
- no effects observed
- Developmental effects observed:
- no
- Conclusions:
- Mice:
Administration of up to 1600 mg/kg (body weight) of the test material to pregnant mice for 10 consecutive days had no clearly discernable effects on nidation or on maternal or foetal survival.
Rats:
The administration of up to 1600 mg/kg (body weight) of the test material to pregnant rats for 10 consecutive days had no clearly discernable effects on nidation or on maternal or foetal survival.
Rabbits:
up to 1600 mg/kg (body weight) of the test material to pregnant rabbits for 13 consecutive days had no clearly discernable effects on nidation or on maternal or foetal survival.
All species: The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differ from the number occurring spontaneously in the sham-treated controls.
Reference
Table 6: Fate summary for mice:
Group |
Material |
Dose** |
Total |
Surviving at term |
||
Mated |
Pregnant |
Total |
Pregnant1 |
|||
341 |
Sham |
0.0 |
25 |
22 |
25 |
22 |
342 |
Aspirin |
150.0 |
25 |
19 |
25 |
19 |
343 |
FDA71 - 86 |
16.0 |
28 |
22 |
28 |
22 |
344 |
FDA71 – 86 |
74.3 |
24 |
22 |
24 |
22 |
345 |
FDA71 – 86 |
345.0 |
25 |
24 |
25 |
24 |
346 |
FDA71 - 86 |
1600.0 |
30 |
23 |
29 |
22 |
* positive control: 150 mg/kg
** administered as a water solution (10 mL per kg of body weight)
1) includes all dams examined at term
Table 7: Reproduction data for mice:
Group |
341 |
342 |
343 |
344 |
345 |
346 |
Dose (mg/kg) |
Sham |
Aspirin** |
16.0 |
74.3 |
345.0 |
1600.0 |
Pregnancies |
||||||
Total No. |
22 |
19 |
22 |
22 |
24 |
23 |
Died or aborted (before Day 17) |
0 |
0 |
0 |
0 |
0 |
1 |
To term (on Day 17) |
22 |
19 |
22 |
22 |
24 |
22 |
Live litters |
||||||
Total No.* |
21 |
19 |
22 |
21 |
24 |
21 |
Implant sites |
||||||
Total No. |
251 |
240 |
263 |
283 |
265 |
267 |
Average/dam* |
11.4 |
12.6 |
12.0 |
12.9 |
11.0 |
12.1 |
Resorptions |
||||||
Total No. * |
19 |
8 |
5 |
12 |
21 |
14 |
Dams with 1 or more sites resorbed |
6 |
5 |
4 |
2 |
9 |
7 |
Dams with all sites resorbed |
1 |
- |
- |
1 |
- |
1 |
Percent partial resorptions |
27.3 |
26.3 |
18.2 |
9.09 |
37.5 |
31.8 |
Percent complete resorptions |
4.55 |
- |
- |
4.55 |
- |
4.55 |
Live foetuses |
||||||
Total No. |
229 |
224 |
255 |
268 |
243 |
250 |
Average/dam* |
10.4 |
11.8 |
11.6 |
12.2 |
10.1 |
11.4 |
Sex ratio (M/F) |
1.16 |
1.07 |
0.90 |
1.00 |
0.94 |
1.02 |
Dead foetuses |
||||||
Total* |
3 |
8 |
3 |
3 |
1 |
3 |
Dams with 1 or more dead |
2 |
6 |
2 |
3 |
1 |
3 |
Dams with all dead |
- |
- |
- |
- |
- |
- |
Percent partial dead |
9.09 |
31.6 |
9.09 |
13.6 |
4.17 |
13.6 |
Percent all dead |
- |
- |
- |
- |
- |
- |
Average Foetus weight, g. |
0.89 |
0.87 |
0.86 |
0.87 |
0.91 |
0.88 |
* includes only those dams examined at term
** positive control, 150.0 mg/kg
Table 8: Fate summary for rats:
Group |
Material |
Dose** |
Total |
Surviving at term |
||
Mated |
Pregnant |
Total |
Pregnant1 |
|||
341 |
Sham |
0.0 |
25 |
25 |
25 |
25 |
342 |
Aspirin |
250.0 |
25 |
23 |
25 |
23 |
343 |
FDA71 - 86 |
16.0 |
25 |
21 |
25 |
21 |
344 |
FDA71 – 86 |
74.3 |
25 |
23 |
25 |
23 |
345 |
FDA71 – 86 |
345.0 |
25 |
23 |
25 |
23 |
346 |
FDA71 - 86 |
1600.0 |
25 |
21 |
25 |
21 |
* positive control 250 mg/kg
** administered as a water solution
1) includes all dams examined at term
Table 9: Reproduction data for rats.
Group |
341 |
342 |
343 |
344 |
345 |
346 |
Dose |
Sham |
Aspirin** |
16.0 |
74.3 |
345.0 |
1600.0 |
Pregnancies |
||||||
Total No. |
25 |
23 |
21 |
23 |
23 |
21 |
Died or aborted (before Day 20) |
0 |
0 |
0 |
0 |
0 |
0 |
To term (on Day 20) |
25 |
23 |
21 |
23 |
23 |
21 |
Live litters |
||||||
Total No.* |
25 |
18 |
21 |
23 |
23 |
21 |
Implant sites |
||||||
Total No. |
279 |
231 |
229 |
270 |
253 |
233 |
Average/dam* |
11.2 |
10.0 |
10.9 |
11.7 |
11.0 |
11.1 |
Resorptions |
||||||
Total No. * |
4 |
62 |
4 |
7 |
7 |
4 |
Dams with 1 or more sites resorbed |
3 |
11 |
3 |
3 |
2 |
3 |
Dams with all sites resorbed |
- |
4 |
- |
- |
- |
- |
Percent partial resorptions |
12.0 |
47.8 |
14.3 |
13.0 |
8.70 |
14.3 |
Percent complete resorptions |
- |
17.4 |
- |
- |
- |
- |
Live foetuses |
||||||
Total No. |
275 |
168 |
224 |
263 |
246 |
229 |
Average/dam* |
11.0 |
7.30 |
10.7 |
11.4 |
10.7 |
10.9 |
Sex ratio (M/F) |
1.07 |
1.06 |
0.87 |
1.07 |
1.18 |
0.75 |
Dead foetuses |
||||||
Total* |
- |
1 |
1 |
- |
- |
- |
Dams with 1 or more dead |
- |
1 |
1 |
- |
- |
- |
Dams with all dead |
- |
1 |
- |
- |
- |
- |
Percent partial dead |
- |
4.35 |
4.76 |
- |
- |
- |
Percent all dead |
- |
4.35 |
- |
- |
- |
- |
Average Foetus weight, g. |
3.68 |
2.39 |
3.92 |
3.94 |
3.77 |
4.04 |
* includes only those dams examined at term
** positive control: 250 mg/kg
Table 10: Fate summary for rats
Group |
Material |
Dose** mg/kg |
Total |
Surviving at term |
||
Mated |
Pregnant |
Total |
Pregnant1 |
|||
341 |
Sham |
0.0 |
18 |
13 |
18 |
13 |
342 |
6-AN* |
2.5 |
20 |
10 |
19 |
10 |
343 |
FDA71 - 86 |
16.0 |
22 |
14 |
19 |
11 |
344 |
FDA71 - 86 |
74.3 |
22 |
13 |
21 |
13 |
345 |
FDA71 - 86 |
345.0 |
20 |
13 |
19 |
12 |
346 |
FDA71 - 86 |
1600.0 |
20 |
14 |
15 |
11 |
* positive contorl: 2.5 mg/kg of 6 aminonicotinamide dosed on Day 9
** administered as a water solution.
1) includes all dams examined at term.
Table 11: Reproduction data for rabbits
Group |
341 |
342 |
343 |
344 |
345 |
346 |
Dose |
Sham |
6-AN** |
16.0 |
74.3 |
345.0 |
1600.0 |
Pregnancies |
||||||
Total No. |
13 |
10 |
14 |
13 |
13 |
14 |
Died or aborted (before Day 29) |
0 |
1 |
3 |
0 |
1 |
3 |
To term (on Day 29) |
13 |
10 |
11 |
13 |
12 |
11 |
Corpora lutea |
||||||
Total No. |
174 |
122 |
195 |
173 |
134 |
139 |
Average/dam mated |
9.67 |
6.42 |
9.29 |
8.65 |
7.05 |
7.72 |
Live litters |
||||||
Total No. |
12 |
10 |
11 |
13 |
10 |
10 |
Implant sites |
||||||
Total No. |
69 |
56 |
60 |
70 |
68 |
62 |
Average/dam |
5.31 |
5.60 |
5.45 |
5.38 |
5.67 |
5.64 |
Resorptions |
||||||
Total No.* |
4 |
2 |
4 |
7 |
9 |
4 |
Dams with 1 or more sites resorbed |
3 |
1 |
3 |
3 |
6 |
1 |
Dams with all sites resorbed |
1 |
- |
- |
- |
2 |
1 |
Percent partial resorptions |
23.1 |
10.0 |
27.3 |
23.1 |
50.0 |
9.09 |
Percent complete resorptions |
7.69 |
- |
- |
- |
16.7 |
9.09 |
Live foetuses |
||||||
Total No.* |
65 |
54 |
56 |
63 |
59 |
58 |
Average/dam |
5.00 |
5.40 |
5.09 |
4.85 |
4.92 |
5.27 |
Sex ratio (M/F) |
0.86 |
0.74 |
1.33 |
1.30 |
1.36 |
1.42 |
Dead foetuses |
||||||
Total No.* |
- |
- |
- |
- |
- |
- |
Dams with 1 or more dead |
- |
- |
- |
- |
- |
- |
Dams with all dead |
- |
- |
- |
- |
- |
- |
Percent partial dead |
- |
- |
- |
- |
- |
- |
Percent all dead |
- |
- |
- |
- |
- |
- |
Average foetus weight |
38.2 |
33.8 |
37.8 |
38.2 |
39.9 |
42.4 |
* included only those dams examined at term
** positive control: 2.5 mg/kg of 6-aminonicotinamide dosed on Day 9
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 600 mg/kg bw/day
- Study duration:
- subacute
- Species:
- other: mice, rat, rabbit
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Toxicity to reproduction: other studies
Description of key information
In a study cited in the available literature (Paterson et al 1979) A reproductive trial involved 31 sows and 27 gilts of Hampshire x Yorkshire x Duroc breeding. Sows and gilts were grouped separately on the basis of ancestry and weight. Outcome groups were randomly assigned to the three treatments. The three treatments consisted of sodium sulfate added to water to give sulfate and total dissolved solids in ppm as follows (1): 320, 620, (2) 1820, 2840 and (3) 3320, 5060.
There were no significant differences in gestation or lactation gains and number or weight of pigs at birth or at weaning. Fecal consistency was normal in all treatments. Water consumption did not differ during gestation but increased during lactation as salt level increased. These results suggest that sulfates up to and including 3320 ppm in water have no significant effect on reproduction in the gilt or sow.
Link to relevant study records
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Supporting study only
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The experiment was conducted to investigate the effects of high sulphate waters given to swine during gestation and lactation
- GLP compliance:
- not specified
- Type of method:
- in vivo
- Species:
- pig
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- During gestation all animals were housed in uninsulated wooden colony type houses located in dry lots. Feed was restricted to 1.8 kg per head daily and fed in individual feeding stalls. Water was availabel ad libitum. Sows were allowed access to feed and water each morning adn evening for 2.0 and 1.5 hr respectively. Saline water was available in the creep area for pigs after 10 days of age
- Route of administration:
- oral: drinking water
- Details on analytical verification of doses or concentrations:
- Sulfate content was determined weekly by a turbidimetric method. The average and their standard deviations for the entire experimental period were as follows: control 320 ± 24 ppm; low sulfate, 1790 ± 35 ppm and high sulfate, 3298 ± 139 ppm.
- Duration of treatment / exposure:
- 30 days postbreeding through 28 days lactation
- Frequency of treatment:
- Water was added ad libitum
- Dose / conc.:
- 320 ppm
- Dose / conc.:
- 620 ppm
- Dose / conc.:
- 1 820 ppm
- Dose / conc.:
- 2 840 ppm
- Dose / conc.:
- 3 320 ppm
- Dose / conc.:
- 5 060 ppm
- Details on study design:
- The reproductive trial involved 31 sows and 27 gilts of Hampshire x Yorkshire x Duroc breeding. Sows and gilts were grouped separately on the basis of ancestry and weight. Outcome groups were randonly assigned to the three treatments. The three treatments consisted of sodium sulfate added to water to give sulfate and total dissolved solids in ppm as follows (1): 320, 620, (2) 1820, 2840 and (3) 3320, 5060.
- Dose descriptor:
- NOAEL
- Effect level:
- 3 320 ppm
- Remarks on result:
- other: Sulfates up to and including 3320 ppm in water have no significant effect on reproduction in the gilt or sow.
- Conclusions:
- Sulfates up to and including 3320 ppm in water have no significant effect on reproduction in the gilt or sow.
Reference
Table 1: Effect of sulfate content of water on reproductive performance
Parameter |
Added sulfates (ppm) |
Gilts |
Sows |
||
0 |
1500 |
3000 |
|||
No. litter |
12 |
13 |
14 |
16 |
23 |
Avg gestation gain, kga |
30.2 |
27.5 |
26.0 |
41.0 |
18.6 |
Avg lactation gain, kgb |
1.5 |
-5.5 |
1.7 |
5.5 |
-7.0 |
Water consumption, litters/day |
|||||
Gestation |
13.3 |
11.2 |
10.6 |
15.1 |
9.2 |
Lactation |
13.6 |
14.2 |
16.8 |
14.4 |
15.5 |
Pigs/litter |
|||||
Total |
11.1 |
10.9 |
10.0 |
9.8 |
11.7 |
Live |
9.6 |
10.0 |
8.2 |
8.7 |
9.9 |
Avg pig birth weight, kgb |
1.4 |
1.4 |
1.5 |
1.3 |
1.5 |
Avg litter birth weight, kg |
13.5 |
13.5 |
11.8 |
11.6 |
14.2 |
No. pigs at 28 days |
6.7 |
6.9 |
6.3 |
6.5 |
6.8 |
28-day pig weight, kg |
6.1 |
6.2 |
6.3 |
6.1 |
6.4 |
28-day litter weight, kg |
40.4 |
42.2 |
40.2 |
39.5 |
42.3 |
aSignificant difference (P 0.01) between gilts and sows
bSignificant difference (P 0.05) between gilts and sows
Justification for classification or non-classification
Calcium sulfate is not toxic to reproduction and has no effect on fertility or development. Consequently, it does not warrant classification under CLP.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
